Invex Therapeutics Ltd. (AU:IXC) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Invex Therapeutics Ltd has issued a final notice regarding the interests of departing director Dr. Megan Baldwin, who served until June 30, 2024. The notice includes Baldwin’s direct and indirect holdings, notably 50,000 unlisted options exercisable at $0.68 until December 1, 2026, through GAJA Holdings Pty Ltd, where she is a director and beneficial holder.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.